$7.01
-0.40-5.4%
Last update: Oct 23, 4:00 PM
Evolus Inc (EOLS) Stock Price, Quote, News & History
EOLSNASDAQ
The FDA has warned Evolus that an Instagram post for Jeuveau is false or misleading and misbrands the drug.
You can purchase shares of Evolus (NASDAQ:EOLS) through any online brokerage.
Other companies in Evolus’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Evolus has a consensus price target of $17.40.
The stock price for Evolus (NASDAQ: EOLS) is $7.01 last updated October 23, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Evolus.
Evolus does not have any upcoming earnings scheduled.
There is no upcoming split for Evolus.
Evolus is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and...
